Mammography Market

Market Synopsis

The global Mammography Market is valued at USD 2.5 Billion in 2024 and is projected to reach a value of USD 5.5 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 10.4% between 2025 and 2035.

During a mammogram, tiny tumors, cysts, and other breast anomalies are highlighted using Analog, Digital, Computer Aided Detection, and Tomosynthesis methods. In the absence of symptoms, screening Mammography is done to look for abnormalities, which can help prompt the treatment of a dangerous medical disease. Diagnostic Mammography is typically performed afterward to assess any unusual clinical findings. As a result, it has several uses in medical facilities like hospitals, specialist clinics, and outpatient surgery and diagnostic facilities. One of the fundamental reasons fueling the markets growth is the rising incidence of breast cancer worldwide.

Additionally, rising public knowledge of the advantages of early detection and screening for breast cancer and the various treatment options available is fueling market expansion. Other growth-promoting aspects include technological developments, such as creating creative 3-dimensional, non-ionizing, and ionizing imaging systems. Furthermore, the market is expanding due to rental services for digital Mammography systems for public hospitals and diagnostic centers that offer affordable imaging solutions. The implementation of supportive government policies encouraging public health and other factors, such as notable advancements in healthcare infrastructure, are anticipated to propel the Mammography market toward expansion.

Market Segmentation

The Mammography market is segmented based on Product, Technology, and Region. Based on the Product segment, the market is segmented into Film Screen Systems, Digital Systems, Analog Systems, and 3D Systems. Furthermore, based on the segment of Technology, the market is further bifurcated into Breast Tomosynthesis, Computer Aided Detection (CAD), and Digital. and based on End Use segment is divided into Hospitals, Specialty Clinics, Diagnostics Centers, and Others.

Based on Product

Digital Systems held a dominating share in the market in 2024

The Digital Systems segment held the most significant market share and is anticipated to expand profitably over the projection period. The increasing need for technologically advanced breast cancer screening systems is one critical reason to propel the expansion. Additionally, the segment is expanding due to its broad commercial availability and increased demand among healthcare professionals. On the other hand, the 3D Systems market is predicted to grow at the quickest rate. This growth is due to several benefits; hospitals & diagnostic clinics are converting to 3D Systems. The reason for this shift is that the 2D Systems are frequently inadequate in identifying all the indications of cancer, leading to a rise in the demand for extra screenings, which raises the cost of diagnostics as a whole.

Based on Technology

Digital Technology dominated the market in 2024

The Digital technology segment revenue is anticipated to expand steadily throughout the projected period. The segment is driven by revolutionized breast cancer screening and diagnostics through advancements in imaging, data management, and analysis. Technologies like digital direct radiography (DR) and digital breast tomosynthesis (DBT), or 3D mammography, have become the standard, offering clearer imaging and better detection of small or hidden lesions, particularly in women with dense breast tissue. The integration of artificial intelligence (AI) further enhances the capabilities of digital mammography by assisting in image interpretation, reducing false positives, and optimizing radiologists’ workflows.

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Based on Regional Analysis

In 2024, the Mammography market size of the North America is USD 0.85 Billion

North America Mammography industry report is driven by a well-established yet dynamic sector, driven by technological advancements, increasing breast cancer awareness, and a robust healthcare infrastructure. The competitive landscape in North America is dominated by key players such as Hologic, GE Healthcare, Siemens Healthineers, and Fujifilm Holdings Corporation, which continue to innovate and introduce advanced mammography systems.

Asia Pacific is projected to grow at the highest CAGR during the forecast period

The Asia Pacific is accounted to grow at the highest CAGR (Compound Annual Growth Rate) during the forecast period. The primary growth drivers include:

• The rising incidence of breast cancer.
• Advancements in breast imaging technologies.
• Significant Research and Development (R&D) expenditures on breast cancer treatments.

As per a study by the Centers for Disease Control & Prevention (CDC), breast cancer is the most common malignancy in most Asian countries, regardless of race or ethnicity. Overall growth is projected to be fueled by the rising incidence of breast cancer and the regions increasing healthcare system. In addition, it is launched that developing nations like China, Japan, and India will accelerate market expansion. Key businesses are also working hard to reach Asia Pacifics growing markets, which is projected to promote growth.

Recent Developments

• In September 2023, At the annual congress of the European Society of Breast Imaging, September 28 to 30, 2023 in Valencia, Spain, Siemens Healthineers presents Mammomat B.brilliant1, a new mammography system with wide-angle tomosynthesis. In tomosynsthesis, the tube moves around the breast at a wide 50° angle, which is the largest angle available on the market. Together with a scan time of around five seconds, this is the fastest wide-angle tomosynthesis on the market – creating a 3D image with high depth resolution in the shortest time possible.
• In November 2023, GE HealthCare announced the release of a new, all-in-one platform of artificial intelligence (AI) apps to support clinicians with breast cancer detection and improved workflow productivity called MyBreast AI Suite. With this initial release, MyBreastAI Suite integrates three AI applications from iCAD including ProFound AI for DBT, SecondLook for 2D Mammography and PowerLook Density Assessment to help support early detection and improve patient outcomes, as well as help radiology departments improve operational productivity.

Competitive Landscape

The Mammography market report is characterized by the presence of both established players and emerging companies, each strive for market share through product innovation, strategic partnerships, and geographic expansion. Industry giants like Hologic Inc. and others. These players focus on improving imaging accuracy, patient comfort, and workflow efficiency while expanding their geographic presence in emerging markets through mobile units and cost-effective systems. Strategic collaborations with healthcare providers, research institutions, and AI firms are common as companies aim to accelerate innovation and gain a competitive edge.

The global Mammography market can be categorized as Product, Technology, End Use, and Region.